Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial

  1. Zeiser, R.
  2. Socié, G.
  3. Schroeder, M.A.
  4. Abhyankar, S.
  5. Vaz, C.P.
  6. Kwon, M.
  7. Clausen, J.
  8. Volodin, L.
  9. Giebel, S.
  10. Chacon, M.J.
  11. Meyers, G.
  12. Ghosh, M.
  13. Deeren, D.
  14. Sanz, J.
  15. Morariu-Zamfir, R.
  16. Arbushites, M.
  17. Lakshminarayanan, M.
  18. Barbour, A.M.
  19. Chen, Y.-B.
Revue:
The Lancet Haematology

ISSN: 2352-3026

Année de publication: 2022

Volumen: 9

Número: 1

Pages: e14-e25

Type: Article

DOI: 10.1016/S2352-3026(21)00367-7 GOOGLE SCHOLAR